Not a member? Sign Up

Reasons for Joining

    Address your challenges through knowledge sharing with peers from our global network of specialists.

    Benchmark your business initiatives with the who's who in the field.

    Hear from industry pioneers how to maximize ROI in today's challenging economy.

    And best of all It's FREE!
Sign in using your existing
Pharma IQ account
Username or Email:

Sign Up    |  Already a member? Sign In
Pharma IQ
20 blog results
   Page  of 2  
  • Contributor:  Absorb This
    Contributor:  01/16/2012  12:00:00 AM EST

    PK, PD, and TB

    I’m always looking for examples of the distinction between pharmacokinetics (PK) and pharmacodynamics (PD), partly to blog about and partly as new material for the undergrads I lecture to in the Pharmaceutical Product Development program at West Chester University. read more

    Tags:  


  • Contributor:  Absorb This
    Contributor:  12/06/2011  12:00:00 AM EST

    How CROs Support Innovation

    Leadership in the field of pharmaceutical and medical device development depends on innovation.  Scientists and engineers with a new idea, who can turn their idea into something tangible, help shape future medical products. read more

    Tags:  


  • Contributor:  Absorb This
    Contributor:  08/11/2011  12:00:00 AM EDT

    Notes From DDI-2011 Conference (Seattle, June 2011)

    What makes a scientific conference great? New, cutting-edge data from experts in the field, to be sure. To me, it’s equally important to have lively, stimulating, insightful discussion after the oral presentations; this is extremely rare, but it really helps illuminate the presentations and put them in perspective. read more

    Tags:  


  • Contributor:  Absorb This
    Contributor:  07/22/2011  12:00:00 AM EDT

    IQPC Transporter Workshop and Conference, London 2011: Clinically Relevant Drug Transporters

    The IQPC conference Clinically Relevant Drug Transporters, held in London June 28-30, was a forum for presentation of case studies and exchange of scientific thought related to drug transporters. read more

    Tags:  


  • Contributor:  Absorb This
    Contributor:  06/30/2011  12:00:00 AM EDT

    Update on “Big Changes for Vivarium Facilities” (May 9th blog post)

    On June 10th, the National Institutes of Health (NIH) issued a statement regarding their adoption of the new Guide for the Care and Use of Laboratory Animals as discussed in my May 9th post in this space. read more

    Tags:  


  • Contributor:  Absorb This
    Contributor:  06/30/2011  12:00:00 AM EDT

    Update on “Big Changes for Vivarium Facilities”

    On June 10th, the National Institutes of Health (NIH) issued a statement regarding their adoption of the new Guide for the Care and Use of Laboratory Animals as discussed in my May 9th post in this space. read more

    Tags:  


  • Contributor:  Absorb This
    Contributor:  06/27/2011  12:00:00 AM EDT

    Report on the 3rd Annual Ocular Diseases & Drug Discovery Conference

    Maybe the most important takeaway message for me from the third annual Ocular Diseases and Drug Discovery conference in Boston, MA at the end of May was the surprising amount of activity in drug development for diseases of the front of the eye, such as glaucoma and dry eye. read more

    Tags:  


  • Contributor:  Absorb This
    Contributor:  06/24/2011  12:00:00 AM EDT

    Shipping Research Materials: Not Like Falling off a Log

    Last month I attended and presented at the 37th annual conference of the Animal Transportation Association in Brussels, including a track on the transport of research-related materials, during which speakers outlined the current state of the shipping industry with regard to biomedical research. read more

    Tags:  


  • Contributor:  Absorb This
    Contributor:  06/21/2011  12:00:00 AM EDT

    Extending BCS-based Biowaivers to Canada: Shaping Policy

    On the 16th of June, the Therapeutic Products Directorate of Health Canada and the Canadian Society for Pharmaceutical Sciences organized a workshop on the Biopharmaceutics Classification System (BCS) to improve their understanding of how the US and EU apply biowaivers in practice. read more

    Tags:  


  • Contributor:  Absorb This
    Contributor:  06/17/2011  12:00:00 AM EDT

    Does Vitamin D Account for Intra- and Inter-individual Variability in CYP3A4 Activity?

    An article published in the May issue of the journal Drug Metabolism and Disposition reveals a seasonal variation in the serum concentrations of the CYP3A substrates sirolimus and tacrolimus, which is temporally and inversely correlated with UV-B light exposure and vitamin D. read more

    Tags:  

20 blog results
   Page  of 2  
Advertisement

Events of Interest
Download Brochure

Please complete the information below to complete your download.

Please note: That all fields marked with an asterisk (*) are required.

First Name *
Last Name *
Job Title *
Company Name *
Email Address *
Telephone *
Country *
Where did you hear about us? *

I would like to receive information about sponsorship and exhibition opportunities

Yes, sign me up for the FREE Pharma IQ e-newsletter, including information on FREE Podcasts, Webinars, event discounts and online learning opportunities.

Columns
Advertisement

Featured Articles